1. Home
  2. SCLXW
  3. SCLXW News

Latest Scilex Holding Company (SCLXW) News on July 26, 2024

Scilex Holding Company Announces Publication of Its Inaugural Sustainability Report
SCLXW

GlobeNewswire

2 days ago

Scilex Holding Company Announces Publication of Its Inaugural Sustainability Report

Scilex Holding Company Strengthens Board of Directors with Appointment of Highly Accomplished Leader in Interventional and Multidisciplinary Spine, Musculoskeletal and Orthopedic Care, Annu Navani, M.D.
SCLXW

GlobeNewswire

3 days ago

Scilex Holding Company Strengthens Board of Directors with Appointment of Highly Accomplished Leader in Interventional and Multidisciplinary Spine, Musculoskeletal and Orthopedic Care, Annu Navani, M.D.

Scilex Holding Company Announces Collaboration to Leverage ACEA Therapeutics’ R&D Expertise and Local Market Connections to Support the Expansion of ZTlido® Program in ex-US and Potentially Provide Additional Access to Patients in Certain Key Markets in Far East Region
SCLXW

GlobeNewswire

9 days ago

Scilex Holding Company Announces Collaboration to Leverage ACEA Therapeutics’ R&D Expertise and Local Market Connections to Support the Expansion of ZTlido® Program in ex-US and Potentially Provide Additional Access to Patients in Certain Key Markets in Far East Region

SCLXW

MT Newswires

24 days ago

Scilex Holding Unit Semnur Pharmaceuticals, Denali Capital Acquisition Propose Merger

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination
SCLXW

GlobeNewswire

24 days ago

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination

Scilex Holding Company to Ring Nasdaq Closing Bell on Friday, July 5th at 4:00PM ET at the Nasdaq MarketSite in Times Square, New York
SCLXW

GlobeNewswire

24 days ago

Scilex Holding Company to Ring Nasdaq Closing Bell on Friday, July 5th at 4:00PM ET at the Nasdaq MarketSite in Times Square, New York

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Month Ended June 30, 2024 and Second Quarter of 2024
SCLXW

GlobeNewswire

25 days ago

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Month Ended June 30, 2024 and Second Quarter of 2024

Scilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC.
SCLXW

GlobeNewswire

a month ago

Scilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC.

Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica)
SCLXW

GlobeNewswire

a month ago

Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica)

Scilex Holding Company (NASDAQ:SCLX) Analysts Just Cut Their EPS Forecasts Substantially
SCLXW

Simply Wall St.

a month ago

Scilex Holding Company (NASDAQ:SCLX) Analysts Just Cut Their EPS Forecasts Substantially

Scilex Holding Company to Present Poster on ELYXYB® (celecoxib oral solution) at the 66th Annual Scientific Meeting of the American Headache Society (AHS) to be Held in San Diego, CA on June 13-16, 2024
SCLXW

GlobeNewswire

a month ago

Scilex Holding Company to Present Poster on ELYXYB® (celecoxib oral solution) at the 66th Annual Scientific Meeting of the American Headache Society (AHS) to be Held in San Diego, CA on June 13-16, 2024

SCLXW

MT Newswires

a month ago

Sector Update: Health Care Stocks Rise Premarket Wednesday

SCLXW

MT Newswires

a month ago

Scilex Holding Signs Commitment Letter for $100 Million Financing; Shares Advance Premarket

Scilex Holding Company Announces 5-Year Term of $100 Million Financing with Royalty-Based Payments and Potential Strategic Transactions with Perigrove and its Portfolio Companies
SCLXW

GlobeNewswire

a month ago

Scilex Holding Company Announces 5-Year Term of $100 Million Financing with Royalty-Based Payments and Potential Strategic Transactions with Perigrove and its Portfolio Companies

SCLXW

Zacks Small Cap Research

a month ago

SCLX: Undervalued and Adding Products

Scilex Holding Company Announces That Many National Pharmacy Chains and Independent Pharmacies Have Begun Stocking GLOPERBA®
SCLXW

GlobeNewswire

a month ago

Scilex Holding Company Announces That Many National Pharmacy Chains and Independent Pharmacies Have Begun Stocking GLOPERBA®

Scilex Holding Company Announces Stocking of GLOPERBA® is Underway in all of the Wholesalers with which Scilex has Stocking Arrangements Throughout the U.S.
SCLXW

GlobeNewswire

2 months ago

Scilex Holding Company Announces Stocking of GLOPERBA® is Underway in all of the Wholesalers with which Scilex has Stocking Arrangements Throughout the U.S.

SCLXW

MT Newswires

2 months ago

Scilex Shares Advance after FDA Approves Production of Gout Medication

Scilex Holding Company announces the U.S. FDA has approved the sNDA for commercial manufacturing of Gloperba® which will be launched in the US in the week of June 10th 2024
SCLXW

GlobeNewswire

2 months ago

Scilex Holding Company announces the U.S. FDA has approved the sNDA for commercial manufacturing of Gloperba® which will be launched in the US in the week of June 10th 2024

Scilex Holding Company Sends Letters to the U.S. Securities and Exchange Commission and Financial Industry Regulatory Authority Regarding Illegal Market Manipulation of the Common Stock of Scilex Holding Company
SCLXW

GlobeNewswire

2 months ago

Scilex Holding Company Sends Letters to the U.S. Securities and Exchange Commission and Financial Industry Regulatory Authority Regarding Illegal Market Manipulation of the Common Stock of Scilex Holding Company

News Flash: 3 Analysts Think Scilex Holding Company (NASDAQ:SCLX) Earnings Are Under Threat
SCLXW

Simply Wall St.

2 months ago

News Flash: 3 Analysts Think Scilex Holding Company (NASDAQ:SCLX) Earnings Are Under Threat

SCLXW

MT Newswires

2 months ago

Scilex to Join MSCI Global Small Cap Index

SCLXW

MT Newswires

2 months ago

Scilex Calls for Investigation Into Alleged 'Naked Short' Stock Manipulation

Scilex Holding Company Announces it has been Added to the MSCI Global Microcap Index
SCLXW

GlobeNewswire

2 months ago

Scilex Holding Company Announces it has been Added to the MSCI Global Microcap Index

Scilex Holding Company Sends Letter to U.S. House of Representatives on Illegal Market Manipulation of the Common Stock of Scilex Holding Company
SCLXW

GlobeNewswire

2 months ago

Scilex Holding Company Sends Letter to U.S. House of Representatives on Illegal Market Manipulation of the Common Stock of Scilex Holding Company

With Scilex Holding Up 36%, Insider Buyers Count Their Returns
SCLXW

Simply Wall St.

2 months ago

With Scilex Holding Up 36%, Insider Buyers Count Their Returns

SCLXW

MT Newswires

2 months ago

Update: Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent Dispute

SCLXW

MT Newswires

2 months ago

Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent Dispute

Scilex Holding Company Announces Final Court Approval of a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s intent to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba®
SCLXW

GlobeNewswire

2 months ago

Scilex Holding Company Announces Final Court Approval of a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s intent to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba®

SCLXW

Zacks Small Cap Research

2 months ago

SCLX Grows Revenue and Expands Portfolio

Scilex Holding Company Provides Information to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common Stock
SCLXW

GlobeNewswire

2 months ago

Scilex Holding Company Provides Information to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common Stock

Scilex Holding Company Announces Closing of $15 Million Registered Direct Offering
SCLXW

GlobeNewswire

3 months ago

Scilex Holding Company Announces Closing of $15 Million Registered Direct Offering

Scilex Holding Company Announces $15 Million Registered Direct Offering
SCLXW

GlobeNewswire

3 months ago

Scilex Holding Company Announces $15 Million Registered Direct Offering

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross and Net Sales for ZTlido® for the First Quarter 2024; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other Administrative Expenses
SCLXW

GlobeNewswire

3 months ago

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross and Net Sales for ZTlido® for the First Quarter 2024; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other Administrative Expenses

Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido® and ELYXYB® for Commercially Insured Patients and the addition of ELYXYB® to a Multi-State Medicaid Pharmaceutical Purchasing Group to Its Purchasing Pool
SCLXW

GlobeNewswire

4 months ago

Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido® and ELYXYB® for Commercially Insured Patients and the addition of ELYXYB® to a Multi-State Medicaid Pharmaceutical Purchasing Group to Its Purchasing Pool

Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend
SCLXW

GlobeNewswire

4 months ago

Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend

Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured Patients
SCLXW

GlobeNewswire

4 months ago

Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured Patients

Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is Needed
SCLXW

GlobeNewswire

4 months ago

Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is Needed

Scilex Holding Company Announces a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s Filing of a sNDA with the FDA Seeking to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba®
SCLXW

GlobeNewswire

4 months ago

Scilex Holding Company Announces a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s Filing of a sNDA with the FDA Seeking to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba®

Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation
SCLXW

GlobeNewswire

4 months ago

Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation

Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canada
SCLXW

GlobeNewswire

4 months ago

Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canada

Scilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc.
SCLXW

GlobeNewswire

4 months ago

Scilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc.

Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of Such Release and Settlement
SCLXW

GlobeNewswire

4 months ago

Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of Such Release and Settlement

Scilex Holding Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
SCLXW

Simply Wall St.

4 months ago

Scilex Holding Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

SCLXW

Zacks Small Cap Research

4 months ago

SCLX Grows Revenue and Boosts Marketing

Scilex Holding Company (NASDAQ:SCLX) most popular amongst private companies who own 57% of the shares, institutions hold 25%
SCLXW

Simply Wall St.

5 months ago

Scilex Holding Company (NASDAQ:SCLX) most popular amongst private companies who own 57% of the shares, institutions hold 25%

Scilex Holding Company Announces Closing of $10 Million Bought Deal Offering
SCLXW

GlobeNewswire

5 months ago

Scilex Holding Company Announces Closing of $10 Million Bought Deal Offering

Scilex Holding Company Sets Launch Price of $595 per 150ml bottle of Gloperba®, its First and Only Liquid Oral Version of the Anti-Gout Medicine Colchicine Indicated for the Prophylaxis of Painful Gout Flares in Adults; Expected Plans to Launch in the First Half of 2024
SCLXW

GlobeNewswire

5 months ago

Scilex Holding Company Sets Launch Price of $595 per 150ml bottle of Gloperba®, its First and Only Liquid Oral Version of the Anti-Gout Medicine Colchicine Indicated for the Prophylaxis of Painful Gout Flares in Adults; Expected Plans to Launch in the First Half of 2024

SCLXW

Zacks Small Cap Research

5 months ago

SCLX Continues to Make Strides

Scilex Holding Company Launches New Website to Showcase Growing Portfolio of Non-Opioid Products and Pipeline Information Updates
SCLXW

GlobeNewswire

5 months ago

Scilex Holding Company Launches New Website to Showcase Growing Portfolio of Non-Opioid Products and Pipeline Information Updates

Scilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend from March 31, 2024 to September 30, 2024
SCLXW

GlobeNewswire

5 months ago

Scilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend from March 31, 2024 to September 30, 2024

Scilex Holding Company Announces $10 Million Bought Deal Offering
SCLXW

GlobeNewswire

5 months ago

Scilex Holding Company Announces $10 Million Bought Deal Offering

Scilex Holding Company Announces Major Initiative with a Leading National Pharmacy Chain to Stock GLOPERBA® in Most of Their Stores Throughout the U.S.
SCLXW

GlobeNewswire

5 months ago

Scilex Holding Company Announces Major Initiative with a Leading National Pharmacy Chain to Stock GLOPERBA® in Most of Their Stores Throughout the U.S.

Scilex Holding Company Announces Acceptance of Abstract for Poster and Oral Presentation at the Annual Meeting of the American Academy of Pain Medicine (AAPM)
SCLXW

GlobeNewswire

5 months ago

Scilex Holding Company Announces Acceptance of Abstract for Poster and Oral Presentation at the Annual Meeting of the American Academy of Pain Medicine (AAPM)

Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement Agreement
SCLXW

GlobeNewswire

5 months ago

Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement Agreement

Scilex Holding Company Announces that ZTlido® Achieves a Major Milestone - Over One Million Patients Treated Since its Launch - and Two Additional Milestones Met
SCLXW

GlobeNewswire

5 months ago

Scilex Holding Company Announces that ZTlido® Achieves a Major Milestone - Over One Million Patients Treated Since its Launch - and Two Additional Milestones Met

Scilex Holding Company Announces Publication in Anesthesiology Journal of Results from an Investigator-Initiated Research Study Using ZTlido® for the Treatment of Chronic Neck Pain¹
SCLXW

GlobeNewswire

5 months ago

Scilex Holding Company Announces Publication in Anesthesiology Journal of Results from an Investigator-Initiated Research Study Using ZTlido® for the Treatment of Chronic Neck Pain¹

SCLXW

Thomson Reuters StreetEvents

6 months ago

Q2 2024 Atlassian Corp Earnings Call

SCLXW

Thomson Reuters StreetEvents

6 months ago

Q4 2023 LPL Financial Holdings Inc Earnings Call

Amex Exploration Announces Closing of C$26 Million Private Placement, Including a Strategic Investment by Eldorado Gold
SCLXW

Newsfile

6 months ago

Amex Exploration Announces Closing of C$26 Million Private Placement, Including a Strategic Investment by Eldorado Gold

Bad Ass Coffee of Hawaii Hits Winning Stride with Unwavering Franchise Growth and Strong Sales Performance
SCLXW

PR Newswire

6 months ago

Bad Ass Coffee of Hawaii Hits Winning Stride with Unwavering Franchise Growth and Strong Sales Performance

E2IP strengthens its Board of Directors for accelerated global scalability. Accomplished CEO and Fortune 500 Executive, Michael J. Loparco, joins E2IP Board of Directors
SCLXW

PR Newswire

6 months ago

E2IP strengthens its Board of Directors for accelerated global scalability. Accomplished CEO and Fortune 500 Executive, Michael J. Loparco, joins E2IP Board of Directors

Global Medical Device Connectivity Market Insights Analysis 2023-2028
SCLXW

GlobeNewswire

6 months ago

Global Medical Device Connectivity Market Insights Analysis 2023-2028

SCLXW

Associated Press Finance

6 months ago

Apple App Store - Top Apps

GM to halve spending on troubled robotaxi unit Cruise in 2024
SCLXW

Reuters

6 months ago

GM to halve spending on troubled robotaxi unit Cruise in 2024

SCLXW

Zacks Small Cap Research

6 months ago

SCLX Sees Accelerating Revenue Growth

Round Table Pizza Shares the Love on National Pizza Day and Valentine’s Day with Sweet Deals
SCLXW

GlobeNewswire

6 months ago

Round Table Pizza Shares the Love on National Pizza Day and Valentine’s Day with Sweet Deals

FAT Brands Foundation Awards Over $250,000 to Local Non-Profits in 2023
SCLXW

GlobeNewswire

6 months ago

FAT Brands Foundation Awards Over $250,000 to Local Non-Profits in 2023

SCLXW

ACCESSWIRE

6 months ago

HSN Champions Emerging Designers Through Exclusive Collaboration With Harlem's Fashion Row

InflaRx N.V.'s (NASDAQ:IFRX) top owners are individual investors with 55% stake, while 23% is held by institutions
SCLXW

Simply Wall St.

6 months ago

InflaRx N.V.'s (NASDAQ:IFRX) top owners are individual investors with 55% stake, while 23% is held by institutions

Turtle Beach (HEAR) Soars 11.9%: Is Further Upside Left in the Stock?
SCLXW

Zacks

6 months ago

Turtle Beach (HEAR) Soars 11.9%: Is Further Upside Left in the Stock?

Soluna Secures 8.8 MW Hosting Deal with Leading Bitcoin Miner
SCLXW

Business Wire

6 months ago

Soluna Secures 8.8 MW Hosting Deal with Leading Bitcoin Miner

Qurate Retail, Inc. Announces Fourth Quarter Earnings Release and Conference Call
SCLXW

Business Wire

6 months ago

Qurate Retail, Inc. Announces Fourth Quarter Earnings Release and Conference Call

Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients
SCLXW

PR Newswire

6 months ago

Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients

D-Wave Names Kirstjen Nielsen, Former Secretary of Homeland Security, to Board of Directors
SCLXW

Business Wire

6 months ago

D-Wave Names Kirstjen Nielsen, Former Secretary of Homeland Security, to Board of Directors

Q1’s Rising Stars: 3 Penny Stocks for Your Must-Watch List
SCLXW

InvestorPlace

6 months ago

Q1’s Rising Stars: 3 Penny Stocks for Your Must-Watch List

Zacks.com featured highlights VirTra, Universal Stainless & Alloy, Carrols Restaurant, BrainsWay and Virco
SCLXW

Zacks

6 months ago

Zacks.com featured highlights VirTra, Universal Stainless & Alloy, Carrols Restaurant, BrainsWay and Virco

2U, Inc.'s (NASDAQ:TWOU) Intrinsic Value Is Potentially 18% Below Its Share Price
SCLXW

Simply Wall St.

6 months ago

2U, Inc.'s (NASDAQ:TWOU) Intrinsic Value Is Potentially 18% Below Its Share Price

Aclaris Therapeutics Announces Top-line Results from 4-Week Phase 2b Trial of ATI-1777 for Mild to Severe Atopic Dermatitis
SCLXW

GlobeNewswire

7 months ago

Aclaris Therapeutics Announces Top-line Results from 4-Week Phase 2b Trial of ATI-1777 for Mild to Severe Atopic Dermatitis

Fortune Rise Acquisition Corporation Receives January Monthly Extension From Sponsor Affiliate to Complete its Initial Business Combination
SCLXW

ACCESSWIRE

7 months ago

Fortune Rise Acquisition Corporation Receives January Monthly Extension From Sponsor Affiliate to Complete its Initial Business Combination

NeuroMetrix to Present at the Emerging Growth Conference on January 10, 2024
SCLXW

GlobeNewswire

7 months ago

NeuroMetrix to Present at the Emerging Growth Conference on January 10, 2024

Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024
SCLXW

GlobeNewswire

7 months ago

Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024

Clene's Phase 2 REPAIR-PD and REPAIR-MD Trials Support Advancement to Phase 3
SCLXW

NewMediaWire

7 months ago

Clene's Phase 2 REPAIR-PD and REPAIR-MD Trials Support Advancement to Phase 3

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales For The Fiscal Year Ended December 31, 2023, Based On Currently Available Information
SCLXW

GlobeNewswire

7 months ago

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales For The Fiscal Year Ended December 31, 2023, Based On Currently Available Information

Exela Technologies Announces Adjournment of Annual Meeting until January 26, 2024
SCLXW

GlobeNewswire

7 months ago

Exela Technologies Announces Adjournment of Annual Meeting until January 26, 2024

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
SCLXW

GlobeNewswire

7 months ago

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients
SCLXW

GlobeNewswire

7 months ago

BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients

Scilex Holding Company Announces Filing of a New Drug Submission (NDS) to Health Canada’s Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canada
SCLXW

GlobeNewswire

7 months ago

Scilex Holding Company Announces Filing of a New Drug Submission (NDS) to Health Canada’s Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canada

Gulf Resources Inc Insider Sells Company Shares
SCLXW

GuruFocus.com

7 months ago

Gulf Resources Inc Insider Sells Company Shares

New partnership aims to advance vaccine against MERS coronavirus
SCLXW

GlobeNewswire

7 months ago

New partnership aims to advance vaccine against MERS coronavirus

SCLXW

News Direct

7 months ago

Trust Stamp secures partnership with Partisia to launch Global Secure Data

LogicMark Expands Product Suite with the Launch of Freedom Alert Mini
SCLXW

GlobeNewswire

7 months ago

LogicMark Expands Product Suite with the Launch of Freedom Alert Mini

Scilex Holding Company Announces that According to Prescription Data from Symphony Health, ZTlido® is the Most Prescribed Non-Opioid Branded Pain Treatment By Pain Specialists
SCLXW

GlobeNewswire

7 months ago

Scilex Holding Company Announces that According to Prescription Data from Symphony Health, ZTlido® is the Most Prescribed Non-Opioid Branded Pain Treatment By Pain Specialists

Scilex Holding Company Announces Results from Market Research with Rheumatologists Reveal a High Degree of Interest in Gloperba® as a Liquid Colchicine Formulation Designed for Precision Dosing
SCLXW

GlobeNewswire

7 months ago

Scilex Holding Company Announces Results from Market Research with Rheumatologists Reveal a High Degree of Interest in Gloperba® as a Liquid Colchicine Formulation Designed for Precision Dosing

Trust Stamp Partners with Partisia and launches Global Secure Data
SCLXW

GlobeNewswire

7 months ago

Trust Stamp Partners with Partisia and launches Global Secure Data

Scilex Holding Company announces major pharmacy initiative with the national leading pharmacy chain to stock ELYXYB® in most of their stores throughout the U.S.
SCLXW

GlobeNewswire

7 months ago

Scilex Holding Company announces major pharmacy initiative with the national leading pharmacy chain to stock ELYXYB® in most of their stores throughout the U.S.

CorMedix Inc. Announces Appointment of Chief Legal Officer
SCLXW

GlobeNewswire

7 months ago

CorMedix Inc. Announces Appointment of Chief Legal Officer

Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024
SCLXW

GlobeNewswire

7 months ago

Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024

SRM Kicks-Off 2024 Sip with Me Marketing Campaign
SCLXW

GlobeNewswire

7 months ago

SRM Kicks-Off 2024 Sip with Me Marketing Campaign

BioAtla Hosting Virtual R&D Day to Highlight BA3071 CAB-CTLA-4 Phase 1 Data in Multiple Solid Tumor Types
SCLXW

GlobeNewswire

7 months ago

BioAtla Hosting Virtual R&D Day to Highlight BA3071 CAB-CTLA-4 Phase 1 Data in Multiple Solid Tumor Types

Share on Social Networks: